Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

LuMend raises $23mm in Series D

Executive Summary

LuMend Corp. (catheter device that opens CTOs--chronic total occlusions--in coronary arteries) raised $23mm in its Series D financing. Lead investor CHL Medical Partners was joined by other new purchasers including Channel Medical Partners, the Richard K. Mellon Foundation, and the Entrepreneur's Growth Fund of RB Webber & Co., and by return participants Morgenthaler Ventures, DeNovo Ventures, ABS Ventures, and Palo Alto Investors.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies